ANA recognizes that, in the rare disease community, we are stronger when working together with those who share common goals. Recently, ANA acted upon this vision by joining Global Genes and formalizing partnerships with VFT and the IWSA.
Focal Point is a webinar series presented by Aniridia North America. This is the second episode, with a focus of Glaucoma in Aniridia. Dr. Peter Netland joins Janelle Collins to give an overview of Glaucoma and to answer a multitude of frequently asked questions that were not covered in episode 1.
2022 was Aniridia North America’s first calendar year after receiving its 501(c)(3) determination from the IRS. Recently, the Board of Directors met for their annual in-person meeting to reflect on the accomplishments of the last year, and to develop a strategic plan for 2023.
Focal Point is a webinar series presented by Aniridia North America. This is the first episode, with a focus of Glaucoma in Aniridia. Dr. Peter Netland joins Janelle Collins to give an overview of Glaucoma and to answer frequently asked questions.
Part of ANA’s vision is to coordinate and synergize its activities and efforts with Aniridia Europe and other international organizations to provide more effective support and affiliations for the global aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited and to participate in the 6th European Aniridia Conference, which was hosted by the Asociación Española de Aniridia in San Juan de Alicante, Spain in June of 2022.
This Symposium was a forum for scientists and medical professionals to discuss their work with each other. The purpose of this overview is to share patient-relevant information from these discussions.
What is ANA? Why was ANA created? Who is ANA for? What does ANA do? All of these questions and more are answered here in our ANA Frequently Asked Questions.
The recent creation of a new nonprofit organization, Aniridia North America (ANA), has been announced by its founding Board of Directors. Aniridia North America is a charitable organization created to represent, serve, and support the North American community of persons affected by aniridia and their families, patient advocacy organizations, and clinicians and scientists. ANA was …
Charlottesville, Virginia – The newly formed Aniridia North America (ANA) announces its first event to strengthen and expand research focused on aniridia and related problems. The 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from North America and around the world. This meeting, like its predecessor, the 2019 John …
The 2021 ANA Symposium: PAX6, Aniridia, and Beyond is the inaugural event for Aniridia North America and is supported by the UVA Ophthalmology and Biology Departments, the Deans of the College of Arts and Sciences and Medicine, as well as the Vision for Tomorrow Foundation, the University of Georgia and and the International WAGR Syndrome …
Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525
Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.
EIN: 86-2917141
